---
title: "Cabozantinib - Renal Cell Carcinoma"
sidebar: mydoc_sidebar
permalink: db08875-mesh-d002292-1.html
toc: false 
---


Path ID: `DB08875_MESH_D002292_1`
{% include image.html url="images/db08875-mesh-d002292-1.png" file="db08875-mesh-d002292-1.png" alt="db08875-mesh-d002292-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C558660">MESH:C558660 </a> | Cabozantinib | Drug |
| <a href="https://identifiers.org/UniProt:P08581">UniProt:P08581 </a> | Hepatocyte growth factor receptor | Protein |
| <a href="https://identifiers.org/UniProt:P35968">UniProt:P35968 </a> | Vascular endothelial growth factor receptor 2 | Protein |
| <a href="https://identifiers.org/UniProt:P07949">UniProt:P07949 </a> | Proto-oncogene tyrosine-protein kinase receptor Ret | Protein |
| <a href="https://identifiers.org/GO:0007169">GO:0007169 </a> | Transmembrane receptor protein tyrosine kinase signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/GO:0001525">GO:0001525 </a> | Angiogenesis | BiologicalProcess |
| <a href="https://identifiers.org/HP:0031377">HP:0031377 </a> | Abnormal cell proliferation | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D002292">MESH:D002292 </a> | Renal cell carcinoma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cabozantinib | DECREASES ACTIVITY OF | Hepatocyte Growth Factor Receptor |
| Cabozantinib | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor Receptor 2 |
| Cabozantinib | DECREASES ACTIVITY OF | Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret |
| Hepatocyte Growth Factor Receptor | POSITIVELY REGULATES | Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway |
| Vascular Endothelial Growth Factor Receptor 2 | POSITIVELY REGULATES | Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway |
| Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret | POSITIVELY REGULATES | Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway |
| Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway | POSITIVELY CORRELATED WITH | Angiogenesis |
| Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Angiogenesis | OCCURS IN | Renal Cell Carcinoma |
| Abnormal Cell Proliferation | OCCURS IN | Renal Cell Carcinoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08875#BE0000915](https://go.drugbank.com/drugs/DB08875#BE0000915)
  - [https://en.wikipedia.org/wiki/Cabozantinib](https://en.wikipedia.org/wiki/Cabozantinib)
